G1 Therapeutics, Inc.
GTHX
|
$4.19
2.2%
2.15%
350K
|
Health Technology
(0.0% 1d) (-1.0% 1m) (54.1% 1y) (0.0% 2d) (0.0% 3d) (-4.2% 7d) (-33.41% volume)
Earnings Calendar: 2024-02-28
Market Cap: $ 218,862,073
http://www.g1therapeutics.com
Sec Filling | Patents | 104 employees
(US) G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib. The company was founded by Kwok-Kin Wong and Norman E. Sharpless on May 19, 2008 and is headquartered in Research Triangle Park, NC.
cancer treatment
Drugs
Cosela (trilaciclib)add to watch list Paper trade email alert is off
Press-releases
G1 Therapeutics to Release First Quarter 2024 Financial Results and Provide Business Update on May 1, 2024
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
GTHX | $4.19 2.2% 2.15% 350K
|
Health Technology
|
| O: 1.72%
H: 4.82%
C: 3.13%
first therapeutics financial results
G1 Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-04 (Crawled : 14:30) - globenewswire.com
GTHX | $4.19 2.2% 2.15% 350K
|
Health Technology
|
| O: 1.06%
H: 1.15%
C: -4.4%
conference therapeutics
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-01 (Crawled : 21:00) - globenewswire.com
GTHX | $4.19 2.2% 2.15% 350K
|
Health Technology
|
| O: -1.32%
H: 4.01%
C: 2.45%
nasdaq grants therapeutics
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-03-01 (Crawled : 21:00) - globenewswire.com
GTHX | $4.19 2.2% 2.15% 350K
|
Health Technology
| Email alert
Add to watchlist
nasdaq grants therapeutics
G1 Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
Published: 2024-02-27 (Crawled : 13:30) - globenewswire.com
GTHX | $4.19 2.2% 2.15% 350K
|
Health Technology
|
| O: 2.61%
H: 5.51%
C: 1.69%
conference health care therapeutics
G1 Therapeutics to Release Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on February 28, 2024
Published: 2024-02-15 (Crawled : 14:00) - globenewswire.com
GTHX | $4.19 2.2% 2.15% 350K
|
Health Technology
|
| O: 1.91%
H: 6.42%
C: 0.0%
year therapeutics financial results
G1 Therapeutics to Continue Pivotal Phase 3 Trial of Trilaciclib in Metastatic Triple Negative Breast Cancer Following Interim Analysis by Independent Data Monitoring Committee
Published: 2024-02-12 (Crawled : 21:00) - globenewswire.com
GTHX | $4.19 2.2% 2.15% 350K
|
Health Technology
|
| O: -44.42%
H: 0.0%
C: -15.66%
breast trilaciclib cancer trial therapeutics negative
G1 Therapeutics Provides Corporate Update at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-08 (Crawled : 12:00) - globenewswire.com
GTHX | $4.19 2.2% 2.15% 350K
|
Health Technology
|
| O: 1.37%
H: 20.0%
C: 16.27%
conference update therapeutics
G1 Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-03 (Crawled : 14:00) - globenewswire.com
GTHX | $4.19 2.2% 2.15% 350K
|
Health Technology
|
| O: -1.61%
H: 1.31%
C: -2.94%
conference therapeutics
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-01-02 (Crawled : 22:00) - globenewswire.com
GTHX | $4.19 2.2% 2.15% 350K
|
Health Technology
|
| O: -1.61%
H: 1.31%
C: -2.94%
nasdaq grants therapeutics
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Last 48 Hours Insiders Buying
CONN | $3.71 1.37% 1.35% 72K
|
Retail Trade
|
21:30
RELL P 2500 | $10.335 2.13% 2.08% 98K
|
Electronic Technology
|
20:01
TGEN P 6000 | $0.6897 39.71% 2.3K
|
Utilities
|
18:30
CMTV P 700 | $15.74 17.43% 12K
|
Finance and Insurance
|
18:30
FNB | $13.63 2.17% 0.0% 2.5M
|
Finance
|
17:30
HNVR | $16.76 2.51% 2.45% 3.5K
|
|
16:30
VUZI P 34500 | $1.315 -2.59% -2.66% 690K
|
Electronic Technology
|
16:00
TPL P 3 | $587.81 0.34% -0.39% 41K
|
Miscellaneous
|
15:00
ETST P 79000 | $0.065 -67.14% 110K
|
Manufacturing
|
11:30
MCFT P 26039 | $21.06 -2.05% -2.09% 130K
|
Consumer Durables
|
00:00
YORW P 29 | $35.625 0.58% 0.58% 56K
|
Utilities
|
19:01
BANF P 256 | $92.29 1.11% 1.09% 92K
|
Finance
|
15:30
RMCF | $3.57 0.28% 2.8K
|
Consumer Non-Durables
|
20:10